Additionally, our study provides a rationale for therapies administered in combination with 5-Aza-Cd to effectively reprogram the transcription of silenced genes in tumor cells based on assessments of the expression levels of EHMT2 and DNMT1. Here, DNMT1 is linked to neoplasm.